No one knows at the moment what the relationship will be between the United Kingdom and the European Union the day after Brexit on 31 October.
The life sciences sector is arguably the most closely harmonized within the European Union. Both medicinal products and medical devices are very much subject to Brussels-driven legislation. In addition to the regulatory issues that would result from Brexit, there could be substantial supply chain interference.
Morgan Lewis is hosting our first Life Sciences Brexit webinar on Wednesday, May 29, 2019. Our lawyers in Morgan Lewis’s London office will discuss the possible consequences of Brexit – with either a deal, no deal, or other potential scenarios.
Speakers at the event include Morgan Lewis lawyers Bruce Johnston and Paul Ranson.
You can attend this event via webinar from 9:00 to 10:00 am (ET)/2:00–3:00 pm (BST). Hope you can make it!
Registration and additional information for the event can be found here.